Observatory for digital health technologies in Europe
The European Commission ’s new report, 'Observatory for Digital Health Technologies in Europe' emphasises the transformative impact of digital health technologies across the EU.
News
93 items-
Discover more
-
VPH at EUPATI Expert Patient Academy event
On 19 May 2026, colleagues from VPH joined a public event in Milan hosted by EUPATI Italia and the IEO European Institute of Oncology to discuss the increasing importance of the role of patient in medical research and innovation.
Discover more -
NAMs and the European Biotech Act: A Strategic Opportunity for In Silico Medicine
A recent event at the European Parliament brought renewed attention to the growing role of NAMs highlighting the forthcoming European Biotech Act as a major opportunity to accelerate the transition toward non-animal science while strengthening Europe’s global competitiveness.
Discover more -
How AI can change sepsis detection and care
A newly FDA-cleared AI system marks a major milestone in the use of real-time artificial intelligence for early sepsis detection in hospitals. This article explores how continuous AI monitoring, machine learning, and personalised medicine could transform critical care while highlighting the scientific, clinical, and regulatory challenges that still remain
Discover more
-
Call for Applications – VPH Young Scientists Committee (2027-2028)
The call for applications for the new VPH Young Scientists Committee is now open! We are seeking motivated early-career researchers in in silico medicine who are eager to actively contribute to and shape the VPH community
Discover more -
Call for Executive Committee Members (2027-2029)
The call for nomination for the new Executive Committee is now open! We are seeking motivated and committed scientists to join the Committee and contribute to advancing the adoption of in silico medicine through leadership, collaboration, and community engagement.
Discover more -
EMA launches pilot for model-informed drug development scientific advice
The European Medicines Agency (EMA) has introduced a dedicated pilot procedure for scientific advice and protocol assistance on model-informed drug development (MIDD) — a significant step forward for the in silico community and a clear regulatory signal that quantitative modelling evidence is coming of age.
Discover more -
VPH at RAPS EURO CONVERGENCE 2026 – Navigating the future of regulation
Our scientific officer, Janaki Raman, joined the global regulatory affairs community in Lisbon for RAPS Euro Convergence 2026 — and in silico medicine was firmly on the agenda.
Discover more -
-
Call for application- VPH Travel Vouchers 2026
The VPH Institute will award up to six Travel Vouchers to support VPH student members attending the VPH2026 Conference in Milan, covering travel, accommodation, and living expenses. Applications will be evaluated based on scientific merit, diversity, and inclusion criteria
Discover more -
Call for applications – VPH Best Presentation Award 2026
The VPH Best Presentation Award recognises the best oral presentation delivered by a VPH student member at the VPH Conference 2026. The winner will receive a certificate and a €500 cash prize
Discover more -
VPH Executive Committee Interview Series: Bernard Staumont on Policy, Regulation and Engagement with Industry
Discover more
